S.R. Pandi-Perumal, M.Sc, is the President and Chief Executive Officer of Somnogen Canada Inc, a Canadian Corporation. He is a well-recognized sleep researcher both nationally and internationally, and has authored many publications. His general area of research interest includes sleep and biological rhythms. He is a well-known editor in the field of sleep medicine and has edited over 20 volumes dealing with various sleep-related topics. His online biography can be viewed at: http://pandi-perumal.blogspot.com
He is an editor of Melatonin: Biological Basis of its Function in Health and Disease (Landes Bioscience, USA, 2005); Neuroendocrine Correlates of Sleep/wakefulness (Springer-Verlag, USA, 2005); Sleep and Sleep Disorders: a Neuropsychopharmacological approach (Landes Bioscience/Eurekha.com and Springer SBM, USA, 2006); Clinical Pharmacology of Sleep (Birkhauser-Verlag, Switzerland, 2006); Sleep disorders: their impact on public health (Informa Healthcare, UK, 2006); Neuroimmunology of sleep (Springer-Verlag, USA, 2007); Neurochemistry of Sleep and Wakefulness (Cambridge University Press, England, 2007); Melatonin: from molecules to therapy (NovaScience Publishers, New York, USA, 2007); Primary Care Sleep Medicine (Humana Press/Springer-Verlag, USA, 2007); Sleep and Psychosomatic Medicine (Informa Healthcare, UK, 2007); Serotonin: physiology, functions, and regulation (Birkhauser-Verlag, Switzerland, 2008); Sleep and Quality of life in medical illness, (Humana/Springer, USA, 2008); Experimental Endocrinology and Reproductive Biology (Science Publishers, NH USA, 2007); Sleep Disorders: Diagnosis and Therapeutics (Informa Healthcare, UK, 2009); Narcolepsy: a clinical guide (Springer, 2010); and Principles and Practice of Geriatric Sleep Medicine (Cambridge University Press, UK, 2010), GABA and Sleep: Molecular, Functional, and Clinical Aspects (Birkhauser-Verlag, Switzerland, 2010), and REM Sleep: Mechanism and Function (Cambridge University Press, England, 2010).